A New MCR Strategy Generating a Collection of Skeletally Diverse Simple Molecules Combinatorially
Abstract:
Background: 1,4 Dihydropyridines (1,4 DHPs), chromeno[4,3-b] quinolines and pyrimido [4,5-b]quinolines are biologically and pharmaceutically important heterocycles. They are also present in many natural products. Many methods have been applied for their synthesis but each method has
its own advantages as well as disadvantages. So, there is a scope to develop a new green and sustainable protocol for their synthesis. Methods: In this context, our aim was to develop an alternative platform for the synthesis of a collection of the small molecules with high scaffold diversity.
Our methods based on Lewis acid catalyzed one-pot synthesis of 1,4-DHP, pyrimido[4,5-b]quinoline and chromeno[4,3-b]quinoline derivatives under room temperature stirring or refluxing condition. Results: We have standardized a protocol for the synthesis of a library of heterocycles such
as 1,4- DHP, pyrimido[4,5-b]quinoline and chromeno[4,3-b]quinoline derivatives representing a collection of skeletally diverse simple molecules decorated with the combination of building blocks by an easy, inexpensive and simple reaction technique. With an optimized reaction condition we prepare
the 1,4- DHPs and pyrimido[4,5-b]quinolines exclusively by iodine but interestingly we failed to prepare the chromeno[4,3-b]quinolones using iodine but it was successfully synthesized by Sc(OTf)3. 1,4-DHPs were synthesized by using 2 molecules of 4-aminocoumarin and 1 molecule of aromatic
aldehydes and pyrimido[4,5-b]quinolines from one molecule each of 6-amino-1,3-dimethyl uracil, aromatic aldehydes, and dimedone by using iodine as a catalyst. Interestingly in the presence of iodine,4-aminocoumarin, aromatic aldehydes, and dimedone results in the formation of 1,4-DHP whereas
catalytic amount of Sc(OTf)3 produces the chromeno[4,3-b]quinoline derivatives in a good to excellent yield. Conclusion: In conclusion, we have developed a mild, easy and simple way for the synthesis of 1,4- DHPs, chromeno[4,3-b]quinoline derivatives and pyrimido[4,5-b]quinolines combinatorially
with a highly optimized reaction condition.The entire optimization protocol reflects the unique catalytic activity of non-metallic Lewis acid catalyst iodine with rare earth-transition metal catalyst Sc(OTf)3. We were able to generate skeletal diversity with the use of different building block
via one synthesis-one skeleton approach. The advantages of our methodology lie in high yields, operational simplicity and chromatographic free separation with high skeleton diversity of the compound.
Abstract:
Background: Azocalix[4] arene derivative based on 2,6-diamino pyridine has been synthesized from diazo-coupling reaction between tetradiazonium salt of calix[4]arene and 2,6-diaminopyridine, and characterized by various spectroscopic methods such as IR, 1HNMR, 13CNMR and Mass spe ... more
Abstract:
Background: Cancer-associated metabolites result from cell-wide mechanisms of dysregulation. The field of metabolomics has sought to identify these aberrant metabolites as disease biomarkers, clues to understanding disease mechanisms, or even as therapeutic agents. Objective: Thi ... more
Abstract:
Background: Despite a reduction in the global burden of malaria, the disease remains responsible for 214 million cases and 438,000 deaths annually with 88% of the mortality occurring in sub-Saharan Africa. Malaria control largely depends on effective chemotherapy. However, the hi ... more
Heterocyclic compounds are enormously crucial in various industries including food, agricultural, cosmetics and pharmaceuticals. Heterocyclic pharmacophores are one of the main chemical components in drug discovery research. A report in 2013 claims that four out of six and nine out of twent ... more
The pyran ring is present in so many useful compounds, such as pharmaceuticals (antibiotics, anti-infectives, cardiovascular agents, neurological modulators, anti-allergic, anti-asthmatic, anti-inflammatory agents, reproductive and genitourinary agents, growth promoters and antidiabetic age ... more